Return investor SBCVC contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

Paige.ai has now raised $75m to date, with the latest funding set to help refine its cancer pathology software offering.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Utimco-backed accountable care services network Aledade attracted GV and Echo Health Ventures for its latest round.

GV took part in a series C round for accountable care services network Aledade that also attracted fellow corporate venturing unit Echo Health Ventures.

Huntington's disease therapy developer BrainVectis, a spinout of research institute Inserm, has been acquired having disclosed just $1m of equity funding in 2016.

The Parkinson's disease therapy developer completed a series A round co-led by AbbVie Ventures, which will also take a board seat at the company.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Grand Pharmaceutical invested $5.6m in Cloudbreak through a licensing agreement, as part of a $25.4m round for the ocular disorder therapy developer.

Cash Capital provided up to $42.4m for the iris recognition technology developer, following a Gree Electric investment in September.